Marion McCourt's Insider Trades & SAST Disclosures

Showing you 100 results sorted by most recent dates.

Show

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Payment of exercise price or tax liability using portion of securities received from the company at price $ 730.81 per share.	16 Dec 2024	759	14,230 (0%)	0%	730.8	554,685	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Dec 2024	8,981	8,981	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Dec 2024	2,332	15,263 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Payment of exercise price or tax liability using portion of securities received from the company at price $ 787.00 per share.	06 Dec 2024	274	14,989 (0%)	0%	787	215,638	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Nov 2024	1,000	6,000	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 381.40 per share.	01 Nov 2024	1,000	13,931 (0%)	0%	381.4	381,400	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 844.61 per share.	01 Nov 2024	1,000	12,931 (0%)	0%	844.6	844,610	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Oct 2024	1,000	7,000	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 1054.06 per share.	01 Oct 2024	1,000	12,931 (0%)	0%	1054.1	1,054,060	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 381.40 per share.	01 Oct 2024	1,000	13,931 (0%)	0%	381.4	381,400	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 1178.73 per share.	03 Sep 2024	1,000	12,931 (0%)	0%	1178.7	1,178,730	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Sep 2024	1,000	8,000	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 381.40 per share.	03 Sep 2024	1,000	13,931 (0%)	0%	381.4	381,400	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 1060.86 per share.	01 Aug 2024	1,137	12,931 (0%)	0%	1060.9	1,206,198	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share.	01 Aug 2024	1,137	14,068 (0%)	0%	372.5	423,487	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Aug 2024	1,137	0	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 1047.11 per share.	01 Jul 2024	1,137	12,931 (0%)	0%	1047.1	1,190,564	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jul 2024	1,137	1,137	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share.	01 Jul 2024	1,137	14,068 (0%)	0%	372.5	423,487	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 980.16 per share.	03 Jun 2024	1,138	12,931 (0%)	0%	980.2	1,115,422	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Jun 2024	1,138	2,274	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share.	03 Jun 2024	1,138	14,069 (0%)	0%	372.5	423,859	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 889.41 per share.	01 May 2024	250	12,931 (0%)	0%	889.4	222,353	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 964.73 per share.	01 Apr 2024	250	13,181 (0%)	0%	964.7	241,183	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 967.50 per share.	01 Mar 2024	358	13,431 (0%)	0%	967.5	346,365	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 934.71 per share.	05 Feb 2024	1,000	13,789 (0%)	0%	934.7	934,710	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 945.61 per share.	01 Feb 2024	273	14,789 (0%)	0%	945.6	258,152	Common Stock
Regeneron Pharmaceuticals,...	McCourt Marion	EVP Commercial	Sale of securities on an exchange or to another person at price $ 873.91 per share.	02 Jan 2024	274	15,062 (0%)	0%	873.9	239,451	Common Stock
Regeneron Pharmaceuticals,...	McCourt Marion	EVP Commercial	Payment of exercise price or tax liability using portion of securities received from the company at price $ 856.71 per share.	12 Dec 2023	5,105	15,336 (0%)	0%	856.7	4,373,505	Common Stock
Regeneron Pharmaceuticals,...	McCourt Marion	EVP Commercial	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Dec 2023	7,649	7,649	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	McCourt Marion	EVP Commercial	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Dec 2023	2,133	21,084 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	McCourt Marion	EVP Commercial	Payment of exercise price or tax liability using portion of securities received from the company at price $ 843.79 per share.	08 Dec 2023	852	18,951 (0%)	0%	843.8	718,909	Common Stock
Regeneron Pharmaceuticals,...	McCourt Marion	EVP Commercial	Payment of exercise price or tax liability using portion of securities received from the company at price $ 844.09 per share.	08 Dec 2023	373	20,441 (0%)	0%	844.1	314,846	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 838.44 per share.	08 Dec 2023	270	20,814 (0%)	0%	838.4	226,379	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 744.66 per share.	01 Aug 2023	250	20,053 (0%)	0%	744.7	186,165	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 710.09 per share.	03 Jul 2023	250	20,303 (0%)	0%	710.1	177,523	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 736.00 per share.	01 Jun 2023	250	20,553 (0%)	0%	736	184,000	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share.	03 Apr 2023	1,100	21,903 (0%)	0%	372.5	409,706	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Apr 2023	1,100	4,450	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 818.80 per share.	03 Apr 2023	1,100	20,803 (0%)	0%	818.8	900,680	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share.	01 Mar 2023	1,100	21,903 (0%)	0%	372.5	409,706	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Mar 2023	1,100	5,550	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 759.89 per share.	01 Mar 2023	1,100	20,803 (0%)	0%	759.9	835,879	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Payment of exercise price or tax liability using portion of securities received from the company at price $ 751.78 per share.	12 Feb 2023	1,276	20,803 (0%)	0%	751.8	959,271	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share.	07 Feb 2023	1,000	23,079 (0%)	0%	372.5	372,460	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Feb 2023	1,000	6,650	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 769.04 per share.	07 Feb 2023	1,000	22,079 (0%)	0%	769.0	769,040	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share.	01 Feb 2023	1,100	23,179 (0%)	0%	372.5	409,706	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Sale of securities on an exchange or to another person at price $ 752.19 per share.	01 Feb 2023	1,100	22,079 (0%)	0%	752.2	827,409	Common Stock
Regeneron Pharmaceuticals,...	Marion McCourt	EVP Commercial	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2023	1,100	7,650	-		-	Non-Qualified Stock Option (right to buy)

Showing 1 to 50 of 101 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades